Sarcoidosis in Beryllium Exposed Workers: A Case‐Case Study
While a number of differences were observed, the only absolute distinguishing features were lack of confirmed beryllium sensitization in Be-exp-Sarc and lack of extra-thoracic manifestations in CBD. These findings suggest that Be-exp-Sarc may be distinct from CBD, and beryllium or some other workplace exposure may possibly play an as yet to be defined etiologic role, although the possibility that these cases could be due to selection bias from heightened surveillance in beryllium workforces cannot be excluded.
Authors
- James Crooks (ORCID: https://orcid.org/0000-0002-0021-5701)
- Mike Van Dyke (ORCID: https://orcid.org/0000-0001-5718-6190)
- Margaret M. Mroz (ORCID: https://orcid.org/0000-0001-5252-5990)
- Karin Pacheco (ORCID: https://orcid.org/0000-0002-2424-5446)
- Lisa A. Maier (ORCID: https://orcid.org/0000-0001-6872-1769)
- Annyce Mayer
- E. Brigitte Gottschall
Institutions
- Colorado School of Public Health (US)
- National Jewish Health (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- American Journal of Industrial Medicine
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1002/ajim.23676
- Citations
- 1
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.33
Funders
- National Institutes of Health